U.S. Chemicals Stock News

DoorDash (DASH) has been in focus after new partnerships with Barnes & Noble, Carter's, Kohl's, and Gap expanded its Marketplace into books, apparel, and broader back to school essentials for same day delivery. See our latest analysis for DoorDash. The latest partnerships come as DoorDash’s share price has gained momentum, with a 30 day share price return of 29.25% and a 90 day share price return of 45.12%, even though the 1 year total shareholder return declined 8.88% while the 3 year total...

Recent trading snapshot and return profile Essent Group (ESNT) recently closed at US$68.07, with the stock down about 0.7% on the day and 2% over the past week, yet up in the past month and past 3 months. For longer term holders, Essent Group shows a 10.4% total return over the past year, with multi year total returns above 40% over 3 years and above 60% over 5 years. See our latest analysis for Essent Group. For context, Essent Group’s short term share price momentum has cooled slightly...

Chipotle Mexican Grill (CMG) is drawing investor attention after announcing its first restaurant in Saudi Arabia later this month, in partnership with Alshaya Group. The move extends a growing presence across the Middle East. See our latest analysis for Chipotle Mexican Grill. The Saudi Arabia opening comes after a period of solid short term momentum for Chipotle Mexican Grill, with a 1 month share price return of 16.07% and a 90 day share price return of 14.21%, even as the 1 year total...

Visa stock has delivered a strong 66.7% return over the past 5 years, yet current checks suggest it no longer looks clearly cheap. The intrinsic value estimate from the Excess Returns model is broadly in line with the market price, while earnings-based multiples lean expensive. Recent news around antitrust litigation and new payment initiatives means investors are weighing solid past gains against what they are now paying for Visa’s future cash flows. A 66.7% gain over 5 years frames Visa as...

Neurocrine Biosciences stock has delivered a 59.0% return over the past five years, yet its current valuation checks still lean on the cheap side rather than pricing in a clear premium. That mix of solid long term performance and a strong value read is what investors now need to weigh. Over the past 5 years, Neurocrine Biosciences has returned 59.0%, which puts recent share price moves in the context of a stock that has already created meaningful value for long term holders. Fresh data from...

Dividend affirmation sets the stage for Pathward Financial stock discussion Pathward Financial (CASH) has affirmed a quarterly cash dividend of $0.05 per share for its fourth fiscal quarter of 2026, payable on October 1 to shareholders of record on September 10. See our latest analysis for Pathward Financial. Alongside the dividend affirmation, Pathward Financial’s recent trading has been steady rather than sharp, with the share price at US$83.68 and a year to date share price return of...

Moderna stock has surged over the past year, yet the company currently screens as expensive on Simply Wall St's broader valuation checks. This raises questions about how much of the good news is already reflected in the share price. Moderna has returned 472.5% over the past year, which puts recent optimism at the center of any discussion about what investors are now paying for future cash flows. The recent positive Phase 3 melanoma vaccine results can support higher long term growth...

Recent commentary around Whirlpool (WHR) has focused on declining revenue, weaker earnings, and a relatively high net-debt-to-EBITDA ratio. Together, these factors are raising fresh investor concerns as customers delay major appliance purchases. See our latest analysis for Whirlpool. Whirlpool’s share price has recently shown a short burst of strength, with a 1-month share price return of 8.26% and a 7-day gain of 1.92%. However, this follows a much steeper reset that leaves the year-to-date...

On 17 August 2026, Sunrun Inc. announced an agreement with Voltus Inc. to supply energy capacity from its residential solar-plus-storage fleet in the PJM and MISO regions to support Voltus’s Bring Your Own Capacity programs for AI hyperscalers. The collaboration highlights how Sunrun is turning thousands of home batteries and smart devices into a virtual power resource that can earn payments for participants while supporting data-center-driven grid demand. Next, we’ll examine how channeling...

Earlier this month, Realty Income Corporation declared its 674th consecutive monthly common stock dividend of US$0.2710 per share, annualized at US$3.252, payable on September 15, 2026 to stockholders of record as of August 31, 2026. Away from its long-running income payouts, Realty Income has also completed and announced sizeable convertible senior note offerings due 2031, reshaping its funding mix and adding a new layer of capital structure complexity for investors to assess. We’ll now...

LKQ stock has had a difficult run over the last few years, yet current valuation checks still suggest the shares lean cheap rather than expensive. The question for investors is whether that gap between weak past returns and a stronger valuation profile is justified. LKQ has declined 45.3% over the last 3 years, which signals that the market has taken a much more cautious view of the stock. Future cash generation and margin resilience can support the current market value, while any setback in...

STERIS (STE) stock has recently drawn attention after its latest share price move, with the company closing at $237.93 on 19 August 2026. Investors are weighing this valuation against its recent performance and financial profile. See our latest analysis for STERIS. Over the past month STERIS has seen an 11.15% 1 month share price return and a 10.02% 3 month share price return, although the year to date share price return is down 4.84% and the 1 year total shareholder return is down 3.23%...

Warrior Met Coal stock has delivered a very strong 442.3% return over the past 5 years, while the current valuation checks send a mixed message with a low overall value score but an intrinsic value estimate from a Discounted Cash Flow (DCF) suggesting the shares trade at a sizeable discount to that estimate. The 442.3% 5 year return shows Warrior Met Coal has already rewarded long term holders in a big way. Ramping production at the low cost Blue Creek mine can support cash flow, although...

NIKE stock is coming off a steep multi year slide, with the share price down about 73.7% over 5 years, while current valuation checks paint a mixed picture that includes a fairly valued intrinsic estimate and an undervalued signal on earnings multiples. The roughly 73.7% share price decline over 5 years suggests investors have sharply reset expectations for NIKE. Recent coverage of NIKE's turnaround efforts and wholesale reset may support a case for earnings and cash flow improvement, while...

Arbor Realty Trust (NYSE:ABR) completed an $825 million commercial real estate mortgage loan securitization, retaining a meaningful portion of subordinated interests. The transaction includes a multi-year reinvestment period that allows principal proceeds to be used for new loans. Arbor Realty Trust plans to use securitization proceeds for both deleveraging and funding future lending activity. The deal affects the company’s funding mix, risk profile and liquidity at a time when financing...

After a strong three year run where JPMorgan Chase has delivered a total return of 154.5%, the stock now sits at an interesting point. The Excess Returns intrinsic value estimate suggests meaningful upside, while the market based multiples look closer to fair and the overall value checks are mixed. JPMorgan Chase has returned 154.5% over the past three years, which puts more focus on whether the current price already reflects much of that strength. Recent headlines around a possible move...

Medtronic (MDT) affirmed its shareholder return policy on 20 August 2026, as the board approved a second quarter fiscal 2027 cash dividend of $0.72 per ordinary share, payable on 16 October 2026. See our latest analysis for Medtronic. Medtronic’s latest dividend affirmation comes after a period of stronger short term share price momentum, with a 90 day share price return of 20.3% and a 30 day gain of 12.19%. Over the same time frame, the 1 year total shareholder return of 4.72% and 3 year...

Somnigroup International has delivered a 50.1% gain over the past 5 years, yet its current valuation checks and intrinsic value estimate point to a stock that may still trade below what its cash flows imply, while not screening as a straightforward bargain across every metric. Somnigroup International's 50.1% return over 5 years suggests long term shareholders have been rewarded, even though more recent periods have been weaker. The pending merger with Leggett & Platt can reshape cash flow...

Why Berkshire Hathaway’s shrinking cash pile matters now Berkshire Hathaway (BRK.A) has started to draw down its long built cash reserves, with holdings of cash and Treasury bills slipping to US$364.7b at 30 June 2026 after a series of large capital moves. Under new CEO Greg Abel, the company committed US$6.8b to acquire homebuilder Taylor Morrison, invested US$10b in Alphabet shares, and spent US$4.5b on Berkshire Hathaway stock repurchases, giving investors fresh data on how its capital...

Meta Platforms stock has pulled back recently, yet valuation checks still point to a possible gap between the share price and what its cash flows may justify. The key question for investors is whether the current weakness is enough to close that gap or if the stock still trades below its intrinsic value estimate. Over the last 3 years Meta Platforms has returned 91.1%, which puts recent share price weakness in the context of a longer period of strong gains. Heavy investment in AI...

XPeng (XPEV) moved into focus after its half year 2026 results showed revenue of CNY 32,777.37 million and a larger net loss. Fresh third quarter guidance added another layer for investors to assess. See our latest analysis for XPeng. XPeng’s latest earnings release and guidance come against a weak recent share price trend, with the stock at US$12.19 and a 90 day share price return that declined 26.34%, while the 1 year total shareholder return fell 47.16%. If XPeng’s results have you...

Aurinia Pharmaceuticals has delivered a 82.4% return over the past three years, which puts fresh attention on whether the current US$16.65 share price still reflects good value or if expectations have already been priced in. Valuation checks currently lean positive, so recent gains raise a fair question about how much upside may be left. The 82.4% three year return suggests investors who backed Aurinia Pharmaceuticals over that period have already been rewarded, which can raise the bar for...

We wouldn't blame Tempus AI, Inc. ( NASDAQ:TEM ) shareholders if they were a little worried about the fact that Eric...

We wouldn't blame WESCO International, Inc. ( NYSE:WCC ) shareholders if they were a little worried about the fact that...